Alpha 1-antitrypsin in acute myocardial infarction
- PMID: 6600394
- PMCID: PMC485205
- DOI: 10.1136/hrt.49.1.26
Alpha 1-antitrypsin in acute myocardial infarction
Abstract
Alpha 1-antitrypsin serum levels were measured in 48 patients with acute myocardial infarction and in 19 control patients either with coronary heart disease without necrosis, or with neither coronary disease nor inflammation. Alpha 1-antitrypsin was significantly raised in the group of patients with acute myocardial infarction. As some patients individually showed no change in alpha 1-antitrypsin levels, however, they were divided into two groups according to the maximum serum levels attained. Patients with non-increasing levels of alpha 1-antitrypsin showed increased mortality and a higher incidence of cardiogenic shock, whereas reinfarction occurred more frequently in the group with high alpha 1-antitrypsin levels. Our findings may suggest that the course of a myocardial infarction is determined not only by the severity of the ischaemic event, but also by the response of the "acute" phase reaction" mechanism. We conclude that a failure of alpha 1-antitrypsin levels to increase after myocardial infarction may be associated with a worse clinical course.
Similar articles
-
Levels of antithrombin III, alpha 2-macroglobulin, and alpha 1-antitrypsin in acute ischemic heart disease.J Lab Clin Med. 1981 Feb;97(2):241-50. J Lab Clin Med. 1981. PMID: 6161197
-
[Prognostic significance of serum alpha 1-antitrypsin levels in myocardial infarction].Sov Med. 1989;(4):23-6. Sov Med. 1989. PMID: 2788308 Russian.
-
Serum alpha 1-antitrypsin activity in ischaemic heart disease.J Indian Med Assoc. 1985 Sep;83(9):297-9. J Indian Med Assoc. 1985. PMID: 3878856 No abstract available.
-
Multivessel versus culprit lesion only percutaneous coronary intervention in cardiogenic shock complicating acute myocardial infarction: A systematic review and meta-analysis.Eur Heart J Acute Cardiovasc Care. 2018 Feb;7(1):28-37. doi: 10.1177/2048872617719640. Epub 2017 Jul 13. Eur Heart J Acute Cardiovasc Care. 2018. PMID: 28703046 Review.
-
["Cardiac power output" an old tool, possibly a modern tool for assessing cardiac pumping capability, as well as for a short-term prognosis in cardiogenic shock due to acute myocardial infarction].Arch Cardiol Mex. 2006 Jan-Mar;76(1):95-108. Arch Cardiol Mex. 2006. PMID: 16749510 Review. Spanish.
Cited by
-
Quantitative proteomics for cardiac biomarker discovery using isoproterenol-treated nonhuman primates.J Proteome Res. 2014 Dec 5;13(12):5909-17. doi: 10.1021/pr500835w. Epub 2014 Nov 7. J Proteome Res. 2014. PMID: 25345801 Free PMC article.
-
Protein-Defined Subspecies of HDLs (High-Density Lipoproteins) and Differential Risk of Coronary Heart Disease in 4 Prospective Studies.Arterioscler Thromb Vasc Biol. 2020 Nov;40(11):2714-2727. doi: 10.1161/ATVBAHA.120.314609. Epub 2020 Sep 10. Arterioscler Thromb Vasc Biol. 2020. PMID: 32907368 Free PMC article.
-
Rosuvastatin Alters the Proteome of High Density Lipoproteins: Generation of alpha-1-antitrypsin Enriched Particles with Anti-inflammatory Properties.Mol Cell Proteomics. 2015 Dec;14(12):3247-57. doi: 10.1074/mcp.M115.054031. Epub 2015 Oct 19. Mol Cell Proteomics. 2015. PMID: 26483418 Free PMC article.
-
Acute-phase protein α1-anti-trypsin: diverting injurious innate and adaptive immune responses from non-authentic threats.Clin Exp Immunol. 2015 Feb;179(2):161-72. doi: 10.1111/cei.12476. Clin Exp Immunol. 2015. PMID: 25351931 Free PMC article. Review.
-
Plasma α1-antitrypsin: a neglected predictor of angiographic severity in patients with stable angina pectoris.Chin Med J (Engl). 2015 Mar 20;128(6):755-61. doi: 10.4103/0366-6999.152485. Chin Med J (Engl). 2015. PMID: 25758268 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials